Abstract Little is known about the uptake or metabolism of essential fatty acids (EFAs) in various mammalian organs. Thus, the distribution of deuterated a-linolenic acid (18:3n-3) and linoleic acid (18:2n-6) and their metabolites was studied using a stable isotope tracer technique. Rats were orally administered a single dose of a mixture (20 mg each) of ethyl D5-18:3n-3 and D5-18:2n-6, and 25 tissues per animal were analyzed for D5-labeled PUFAs at 4, 8, 24, 96, 168, 240, 360, and 600 h after dosing. Plasma, stomach, and spleen contained the highest concentrations of labeled precursors at the earliest time points, whereas other internal organs and red blood cells reached their maximal concentrations at 8 h. The time-course data were consistent with liver metabolism of EFAs, but local metabolism in other tissues could not be ruled out. Brain, spinal cord, heart, testis, and eye accumulated docosahexaenoic acid with time, whereas skin accumulated mainly 20:4n-6. On average, ?16-18% of the D5-18:3n-3 and D5-18:2n-6 initial dosage was eventually accumulated in tissues, principally in adipose, skin, and muscle. Approximately 6.0% of D5-18:3n-3 and 2.6% of D5-18:2n-6 were elongated/desaturated and stored, mainly in muscle, adipose, and the carcass. The remaining 78% of both precursors was apparently catabolized or excreted.-Lin, Y. H., and N. Salem, Jr. Whole body distribution of deuterated linoleic and a-linolenic acids and their metabolites in the rat. J. Lipid Res. 2007Res. . 48: 2709Res. -2724 
Although many studies have focused upon the liver as the primary site for essential fatty acid (EFA) metabolism in mammals, relatively little is known about other organs with respect to their uptake of EFA precursors and products or the manner in which these fatty acids are distributed to them. In most human studies, the blood compartment is the only sample available and liver activity must be inferred from plasma analysis, in some cases with the aid of mathematical modeling (1) (2) (3) . However, efforts to understand and model human EFA metabolism depend upon a rigorous description of EFA metabolism in several organ systems. Although this cannot be achieved in humans for ethical reasons, animal studies allow a complete description of the role of various organs in processing EFAs in vivo. Such a description would include the uptake of the EFA precursors linoleic acid (18:2n-6) and a-linolenic acid (18:3n-3) into various organs as well as their metabolism to various products along the n-3 and n-6 EFA pathways.
Previous investigations include stable isotope studies in primates and have provided analyses of EFA uptake and metabolism of the liver, nervous system, and blood stream (4) and, in some cases, other internal organs such as the heart, lung, and kidney (5). Fu and Sinclair (6, 7) provided a description of the radiolabeling of many guinea pig tissues with [ . Whole body balance methods for the analysis of EFA retention in various tissues and b-oxidation (8) as well as those based on breath test using various 14 C-labeled EFAs led to the conclusion that the fate of the bulk of the EFAs was b-oxidation (9) .
It would be valuable to extend these studies to a description of EFA uptake and metabolism in all of the major tissues in mammals under well-controlled and defined dietary conditions. This information is a first step in the understanding of the EFA requirements and the ability to elaborate and use long-chain polyunsaturates of various organs and tissues throughout the body. The present study was thus designed to investigate the incorporation and metabolism of stable isotope-labeled EFAs into various rat tissues over an extended period. A single oral dose of both 2 H 5 -18:3n-3 and 2 H 5 -18:2n-6 was given to young adult male rats consuming a defined diet containing 15% of total fatty acids as 18:2n-6 and 3% as 18:3n-3. Negative chemical ionization gas liquid chromatography-mass spectrometry (GC-MS) analysis was used for the quantification of the precursors and their individual metabolites in 25 components from 4 to 600 h after dosing.
MATERIALS AND METHODS

Animals and diet
All animal procedures were carried out in accordance with the National Institutes of Health animal care and welfare guidelines, and the protocol was approved by the National Institute on Alcohol Abuse and Alcoholism Animal Care and Use Committee. Time-pregnant, female Long-Evans hooded rats on the third day of gestation were obtained from Charles River (Portage, MI) at the age of 13 weeks and maintained in our animal facility under conventional conditions with controlled temperature (22jC) and illumination (12 h; 6:00 AM to 6:00 PM); food and water were provided ad libitum. The rats were immediately placed on a pelleted custom diet upon arrival, which was modified from the AIN-93G formulation (10) as described previously (11) . In brief, lipid-extracted casein was used, carbohydrate sources were modified, and fat sources (10 wt%) were controlled. Fat sources were 77 g of hydrogenated coconut oil, 18 g of safflower oil, and 5 g of flaxseed oil per kilogram of diet. The fatty acid distribution in the fat was 77% saturated fatty acids, 4% monounsaturated fatty acid, 15% linoleate, 3% a-linolenate, and only traces of longer chain EFAs (C20 and C22). The male offspring were weaned onto the same diet at 3 weeks of age. At 7 weeks of age, nine rats with a body weight of 186 6 7 g (mean 6 SD) were fasted overnight and administrated a single oral dose of 20 mg each of 2 H 5 -18:3n-3 and 2 H 5 -18:2n-6 ethyl ester using olive oil as the vehicle or vehicle oil only for a control animal. The animals were then maintained ad libitum on the above-described diet for the remainder of this "pulse-chase" type of experiment. One animal was euthanized at each of the following time points after dosing with the isotopic tracers: 4, 8, 24, 96, 168, 240, 360, and 600 h. A control animal was euthanized at 0 h. Each rat was dissected into a total of 25 components as detailed below. 
Isotope and chemicals
Tissue collection
Rats were asphyxiated in carbon dioxide after fasting overnight before euthanasia with the exception of those euthanized at 4 and 8 h, which were given access to food immediately after dosing. Blood was drawn by cardiac puncture when rats were unconscious and separated into plasma and red blood cells (RBCs) at 1,800 g for 10 min at 4jC. The head was severed at the neck, and the brain and eye (with associated glands) were removed. The body was placed on ice during this second stage of dissection. Gallbladders were removed before liver and other abdominal tissue collection to avoid contamination with bile fluid. The thymus, salivary, and thyroid glands were dissected out. Abdominal organs collected include the heart, lung, liver, pancreas, kidney, spleen, bladder, and testis. The gastrointestinal (GI) tract (from duodenum to anus) was emptied and rinsed with ice-cold saline (0.85% NaCl); the stomach was subsequently removed and treated similarly. The spinal cord was then separated from the vertebrae. Subsequently, skin with fur was collected from both the skull and carcass, visible subcutaneous fat and visceral fat were pooled, and muscle (skeletal muscle and chest) and bones (short-carpal bones; irregular vertebrae, long humerus, radius, ulna, femur, tibia; flat scapula, ilium) with periosteum and marrow were collected. The brown adipose tissue under the neck skin and along the vertebrae was collected. The remaining carcass contained the skull, ribs, cartilage, paws, tail, and the remaining parts not listed above. After dissection, organs were carefully washed with cold normal saline, blotted, wrapped frozen on dry ice, and then stored in a 280jC freezer until analysis. Each of the 25 components listed in Table 1 were analyzed individually. In some cases, for graphic purposes, individual tissues were combined to make 11 categories (adipose, skeleton, circulatory system, digestive system, muscle, nervous system, respiratory system, skin, urogenital system, and the remaining carcass), as detailed in Fig. 1 . Excretions were not collected.
Homogenization, lipid extraction of various tissues, and derivatization reactions
Large organs/tissues were thoroughly diced into fine pieces at 4jC before extraction. Organs were homogenized in methanol containing 0.2 mM butylated hydroxytoluene (BHT; 10 ml for 1 g of tissue); one aliquot of homogenate (?100 mg of tissue wet weight) was used for total lipid extraction. A motorpowered small tissue homogenizer was used for tissue disruption (Omni International, Marietta, GA). Bones were cut into smaller pieces, cooled with liquid nitrogen, and pulverized into a fine powder with a mortar and pestle over dry ice. One gram of this bone powder was placed in 10 ml of methanol-BHT and sonicated for 10 min (12) . The skin/fur was cut to separate the skin from fur and the subcutaneous fat, which was combined with the white adipose tissue. Skin samples of ?1 cm 2 , containing both epidermis and dermis, were taken from various parts of the rat body and diced into ,3 mm 2 pieces, mixed completely, and then homogenized (10 ml of methanol-BHT for 1 g of skin sample). One gram of fur from various areas was cut into lengths of ,3 mm over dry ice and sonicated in 10 ml of methanol-BHT for 20 min. The carcass was handled similarly to bone: after freezing on dry ice and powdering with a mortar and pestle, 5 g of carcass powder was sonicated in 50 ml of methanol-BHT. White adipose tissue from different body locations was diced and mixed well, and ?0.25 g of adipose was homogenized in 5 ml of chloroform-methanol (2:1)-BHT solution.
One aliquot of homogenate or sonicate from each tissue was used to extract total lipids of the tissues according to Folch, Lees, and Sloane-Stanley (13) . The total lipid extract was dried under a stream of nitrogen and transmethylated using boron trifluoride in methanol (14 g/l; Sigma Chemical, St. Louis, MO) as described by Morrison and Smith (14) and modified by Salem, Reyzer, and Karanian (15) . The internal standard, 22:3n-3 ethyl ester (60 nmol/sample), was added to each sample before lipid extraction. A separate aliquot of the homogenate was hydrolyzed and derivatized with pentafluorobenzyl (PFB) reagent [PFB bromide, diisopropylamine in acetonitrile (1:100:1,000, v/v/v)] to form fatty acid PFB ester for GC-MS negative chemical ionization analysis (16) for deuterium-labeled fatty acids. For GC-MS analysis, 2.5 nmol/sample of 22:3n-3 ethyl ester was added at the beginning of the lipid extraction as an internal standard. quantitated according to a previously reported method (17) . For the measurement of unlabeled fatty acid concentrations in tissues for the calculation of enrichment, GC-flame ionization detection analysis was performed on an Agilent 6890 Plus LAN system as described previously (15) .
Data analysis
Isotopically labeled EFA data were expressed as the concentration, in nanomoles per gram of tissue wet weight or, for plasma and RBCs, as nanomoles per milliliter. Because animals were euthanized over a period of 25 d while still being fed nonlabeled food and growing, initial body weight and tissue weight were lower than at the end of the experiment (Fig. 1, bottom) . Thus, the fatty acid concentration values were normalized to the body weight by multiplying the concentration values by the ratio of the tissue weight at each time point to the initial (time 5 0) tissue weight. The amount of each labeled fatty acid per tissue was obtained by multiplying the concentration by the weight of the whole tissue. The distribution of each labeled fatty acid in the rat whole body was computed as a percentage by dividing the amount of the labeled fatty acid in a particular tissue by the sum of the labeled fatty acid in all of the organs/tissues 3 100 at each time point. Areas under the curves were obtained by integrating the areas under the curves as a function of time using a trapezoid estimation method (18) .
RESULTS
Tissue dissection
Animals were dissected into 25 components, which may be subgrouped into 11 biological systems (Fig. 1) . The proportion of total rat body weight that was recovered in harvested tissues at the various time points was 82 6 5% (n 5 9). Of this total collected tissue, the largest components were muscle (29 6 2%), skin (16 6 1%), adipose (13 6 3%), bone (4.7 6 0.8%), and liver (4.6 6 0.4%); the remaining carcass amounted to 20 6 1%. The weight of the circulatory system, nervous system, respiratory system, urogenital system, and remaining digestive system constituted the remaining ?12% of total tissue wet weight (Fig. 1) . During the 4 week duration of the experiment, body weight increased by ?2-fold from 194 to 383 g. During this period, there was an increased percentage of tissue as adipose, but the proportion of various organs and tissues in the various biological systems was relatively constant. The tissue distribution of precursors and their main intermediates as well as the metabolic end products was identified and determined in all 25 components harvested, as presented below.
Time course of deuterated n-3 EFA concentrations in principal organs
The appearance and disappearance of 2 H 5 -18:3n-3 in various tissues and its major in vivo metabolites are presented in Fig. 2 as bar graphs at various time points after a single oral dose of 2 H 5 -18:3n-3. The precursor was at its maximal concentration (C max ; in nmol/g or nmol/ml) at the first experimental time point of 4 h in the stomach (112), plasma (15.6), and spleen (12.4) and decreased sharply by 8 h. However, several other tissues also achieved C max precursor concentrations at ?8 h, including RBCs The total amount of 2 H 5 -18:3n-3 per organ was computed from the concentration data, and the tissue totals were added to calculate the whole body total. The data for each tissue system were then expressed as a percentage of the whole body total 2 H 5 -18:3n-3 at each time point (Fig. 3A) . At 4 h, a large amount of the 2 H 5 -18:3n-3 was observed in the GI tract (15%), muscle (20%), and liver (27%). By 8 h, the GI amount was rapidly decreasing, although still present (6%), liver had increased significantly to 39% of total, and muscle (19%) and adipose (16%) contained significant proportions of the whole body 2 H 5 -18:3n-3. By 24 h, GI tract 2 H 5 -18:3n-3 was essentially gone, liver content had decreased (19%), and muscle (27%) and skin (14%) percentages had increased; adipose 2 H 5 -18:3n-3 has increased dramatically to 34% of total. By 96 h, liver 2 H 5 -18:3n-3 was nearly gone, with adipose containing the bulk (71%) and substantial amounts also in the skin (20%). Later Table 1 ) and then organized into 11 categories, as depicted in the lower panel. The percentage of the total collected tissue is given for each of these 11 organ systems at each time point between 0 and 600 h in the top panel.
The mean values 6 SD are given for nine rats from 7 to 11 weeks old in the bottom panel. The body weight of each rat at the time of euthanasia is also given at the bottom of the figure. RBC, red blood cell.
time points were similar to the 96 h time point in that the major reservoirs for 2 H 5 -18:3n-3 were primarily adipose and, to a lesser extent, skin and muscle. Very little 2 H 5 -18:3n-3 was detected in the nervous system. An estimate of the amount of 2 H 5 -18:3n-3 recovered in the whole body was made by adding the amounts found in the individual compartments (Fig. 3B) . After the initial period, in which it was noted that some 2 H 5 -18:3n-3 label Essential fatty acid metabolism in rat organswas lost as a result of rinsing of the GI system after dissection, a plateau was reached by 96 h and maintained until the end of the experiment at 600 h at a level of ?20% of the initial dose. Fig. 4 . The contents of each of these metabolites were summed at each time point and for each tissue to make a total value, and then the percentage of the total was plotted for each of the main organ systems. Initially, at 4 h, in addition to the high liver content (14%), carcass (21%), muscle (17%), and skin (18%) also contained substantial percentages of the whole body n-3 metabolites. The GI system reached its peak level of n-3 metabolites, composed primarily of 2 H 5 -20:5n-3, at 4 h, and this diminished during the next several days. The liver content was substantial, reaching its peak (50%) after 24 h; thereafter, it decreased to 30% at 96 h and then continued to decrease gradually during the remainder of the 600 h experiment. Muscle was labeled rapidly with n-3 metabolites, with a substantial percentage on the first day, and thereafter continued to accrete, becoming the predominant tissue after 168 h; the n-3 metabolite here was primarily 2 H 5 -22:6n-3. Adipose content of n-3 metabolites was initially 8%, increasing gradually afterward until ?168 h (16%), after which it remained almost constant. Skin labeling was interesting in that it reached its maximum metabolite value of 18% at the initial time point of 4 h and then diminished afterward to 4% by 600 h. The circulatory system maintained a consistent percentage of ?1-3% during the entire experimental period. The nervous system increased gradually and reached ?2% at the end of study, although accounting for only 1% of the total tissue weight. Initially, the n-3 fatty acid metabolites were composed mainly of 
Concentration time-course plots of deuterated n-6 EFA in principal organs
The appearance and disappearance of 2 H 5 -18:2n-6 and its in vivo metabolites in various organs are presented in Fig. 5A , B as bar plots of isotope concentration versus time after a single oral dose of 2 H 5 -18:2n-6. The 2 H 5 -18:2n-6 precursor exhibited a maximal concentration at 8 h for plasma, RBCs, and all organs except testis and eye, in which 2 H 5 -18:2n-6 was taken up more slowly and reached a peak after 24 h. As might be expected, the stomach isotope content reached its greatest concentration at the earliest time points used, reaching 105-120 nmol/g tissue weight at 4-8 h. The pattern of precursor uptake for plasma, spleen, and heart resembled the uptake of 2 H 5 -18:2n-6 in stomach, with a high 4 h value and peaking at 8 h. After reaching its maximal value, 2 H 5 -18:2n-6 disappearance from the plasma, RBCs, liver, stomach, and spleen was rapid. Brain and spinal cord did become rapidly labeled with the 2 H 5 -18:2n-6, although the concentrations were relatively low. A high concentration of 2 H 5 -18:2n-6 was reached in the liver, stomach, kidney, heart, and lung.
As expected in a metabolic sequence of reactions, each metabolite of 2 H 5 -18:2n-6 generally appeared in each tissue, with a slight delay with respect to its precursor. An exception was 2 H 5 -22:5n-6, which generally reached its maximum at about the same time as the 2 H 5 -22:4n-6 maximum within the resolution of this experiment. The plasma and liver exhibited essentially the same maxima for each successive 2 H 5 -18:2n-6 metabolite, indicating a rapid equilibration of these compartments. As the principal location of fatty acid metabolism, liver exhibited the greatest concentrations of The whole body distribution of the 2 H 5 -18:2n-6 precursor at different times after dosing is presented in Fig. 6A . Again, the total amount of 2 H 5 -18:2n-6 per organ was computed from the concentration data, and the organ totals were added to calculate the whole body total. The data for each organ system were then expressed as a percentage of the whole body total 2 H 5 -18:2n-6 at each time point. At 4 h after administration, ?16% of the 2 H 5 -18:2n-6 appeared in the GI tract, with 12% in liver, whereas muscle was the principal depot, as it accumulated 31% of the whole body total. Approximately 10% each appeared in skin and adi- An estimate of the amount recovered in the whole body was made by adding the amounts of 2 H 5 -18:2n-6 found in the individual compartments (Fig. 6B) . After the initial period, when some of the 2 H 5 -18:2n-6 label was lost as a result of rinsing of the GI system after dissection, a plateau was reached by 96 h and maintained until the end of the experiment at 600 h at a level of ?20% of the initial dose, similar to the findings for 2 H 5 -18:3n-3. H 5 -22:5n-6 in liver began at a high level (33%) at 4 h and reached a maximum (48%) at 24 h, with a subsequent slow decay over the course of this study (Fig. 7A) . The n-6 metabolite that decreased in the liver after 96 h appeared to be transferred mainly to muscle, with a smaller increment in adipose. The circulatory system maintained a percentage of 2-5% during the entire experimental period. n-6 metabolites in the GI tract peaked at 4 h, in conformity with the early peak in 2 H 5 -18:2n-6, and then decreased throughout the 600 h time course of the experiment to 1.5% of the whole body total. Similar to the case for the n-3 metabolites, muscle played an important role in the tissue distribution of n-6 metabolites, with ?8-15% in the first days and increasing to ?35% by 360-600 h. N-6 metabolites in skin were initially very low at 4 h but thereafter increased to a level of ?14-15% from 96 to 240 h. The nervous system eventually accumulated ?1% of total body n-6 metabolites, mainly in the form of (Fig. 7B) .
Maximal total amount of precursors and principal metabolites in various organs
The total amount of the various deuterated fatty acids in each organ at the time point at which it reaches its maximal value (D max ) was calculated. Thus, this calculation was made for (Table 1) . White adipose tissue became the main repository for the two precursors, accounting for 14.5% of the dose for 2 H 5 -18:3n-3 and 16% of the dose for 2 H 5 -18:2n-6, although this content was not reached until 168 h after dosing. The white adipose had much greater precursor content than did the brown adipose, likely because of its greater tissue weight. Liver was a somewhat distant second with respect to content of unmodified EFA precursor, with 4.5% of the H 5 -20:4n-6, respectively) was greatest after 360-600 h. The principal metabolites in skin and adipose exhibited maxima in the 168-360 h range. The carcass also contained a considerable amount of both precursors Essential fatty acid metabolism in rat organsand major metabolites, perhaps because of small muscles (including the diaphragm and rib muscles) and bits of adipose that could not be readily dissected out. The digestive system did not exhibit a very substantial percentage of the dose at any time point, likely because of the absence of sampling at very short time points (,4 h). It is noteworthy that the distribution (defined in Data Analysis above) of the precursors To quantify all 25 tissues with respect to the plot of the total amount per organ at each time point, the area under the curves was calculated ( (16.6) , followed by muscle (14.6), adipose (9.8), and liver (6.0).
DISCUSSION
Fate of n-3 and n-6 precursors
To our knowledge, no previous study has attempted to follow the uptake and metabolism of the EFAs 18:2n-6 and 18:3n-3 throughout all of the various tissues in a mammal. This study systematically followed both the time course and the individual tissue accumulations of a pulse of deuterated C18 EFA precursors along with their principal metabolites in rats consuming a controlled and well-defined diet. Because of the magnitude of this study design, it was necessary to fix some variables, such as the diet composition and the animal age, rather than to study variations in these parameters. It must be conceded that somewhat different results may have been obtained had the macronutrients or EFA content of the diet been altered or had younger or older animals been studied. These are important variables for future study. The pulse of isotope gives a rapid early enrichment that becomes progressively diluted with subsequent dietary EFA, with the result that subsequent metabolism has less isotope per molecule metabolized.
In the past, many researchers have emphasized differences in metabolism for 18:2n-6 and 18:3n-3. One common observation has been the low level of 18:3n-3 in tissue complex lipids, as there is often an abundance of 18:2n-6 in these pools (19) . It is instructive then to compare the disposition of each EFA precursor in terms of the tissue disposition, anabolic metabolism, and catabolism/excretion and to compare the n-3 and n-6 families in these respects. The net accumulation of the two labels in tissue pools was very similar, with both approaching 20% of the original dosage (compare Figs. 3B and 6B) . Most of this disposition occurred within the first 100 h after dosing, with little subsequent change in the ensuing 500 h. This time course coincides with the uptake of the C18 EFA precursors into adipose tissue, which is nearly complete by 100 h after dosing. It is likely then that exposure to oxidative catabolism occurs during the absorptive and circulatory phases but that little catabolism occurs after deposition in adipose.
An attempt to estimate the overall disposition of the two EFA precursors was made by averaging the values for all tissues at time points between 24 and 600 h (with the period before 24 h excluded). The remainder of the deuterated precursors not accounted for was assumed to have been excreted and/or catabolized, although this was not measured directly. There was a remarkable similarity for 2 H 5 -18:2n-6 and 2 H 5 -18:3n-3 in the percentage of dose deposited in the various tissues (?16-18%) and also in the amount that was catabolized (?79%) (Fig. 8) . About twice as much of the 2 H 5 -18:3n-3 (6%) was accumulated as its longer chain, more unsaturated analogs than was the 2 H 5 -18:2n-6 (2.6%) during the course of this 600 h experiment. This result might not be predicted from information emphasizing that the n-3 acid is "rapidly lost" from the body. The high extent of presumed catabolism for both EFA (78.2% and 78.9%) confirms previous studies by Cunnane (20) , who observed that 75-85% of C18 PUFAs Essential fatty acid metabolism in rat organswere b-oxidized and served as substrates for carbon recycling and de novo lipid synthesis (21-23). Bell, Dick, and Porter (24) also observed very active catabolism of 2 H 5 -18:3n-3 in rainbow trout. Thus, from a whole body perspective, our study indicates very similar processing for the n-3 and n-6 fatty acid precursors. The greater accumulation of 2 H 5 -18:3n-3 metabolites relative to those of 2 H 5 -18:2n-6 should not be construed, however, to indicate greater overall metabolism of the nonlabeled pools. The plasma and liver isotopic enrichment, for example, are much greater for the 2 H 5 -18:3n-3 than for the 2 H 5 -18:2n-6, as a result of the much larger endogenous pools of unlabeled 18:2n-6 relative to those of 18:3n-3. At the 4 h time point, the enrichment of liver and plasma 2 H 5 -18:3n-3 was .14-and 8-fold, respectively, that of 2 H 5 -18:2n-6. Thus, an equivalent rate of anabolic metabolism in micromoles per unit of time at early "pulse" time points would lead to a much greater number of deuterated metabolite molecules for the n-3 pathway. The multiple pools of various metabolites in various tissues make it difficult to have precise calculations of rate. The 2-fold greater accumulation of 2 H 5 -18:3n-3 metabolites relative to those of 2 H 5 -18:2n-6 is in fact less than the difference in enrichments, and it is likely correct to say that there was Values shown are mmol*h. The trapezoid rule was applied to calculate the area under the curve from 0 to 600 h; ND indicates nondetectable; Tr, trace values (i.e., ,0.005 mmol*h). Boldface numbers indicate the greatest values for the 25 components examined. still more overall metabolism occurring in the n-6 pathway. The distribution of isotope label given as a single dose in this pulse-chase type of study is a good indicator of the fate of a dietary bolus of 18:2n-6 and 18:3n-3.
